Association of a DNA damage response deficiency (DDRD) assay and prognosis in early-stage esophageal adenocarcinoma.Richard Turkington, Richard D. Kennedy, Claire Harrison et al.|Journal of Clinical Oncology|2014Cited by 3
PD-L1 expression and response to neo-adjuvant chemotherapy in esophageal adenocarcinoma.Eileen E. Parkes, Richard Turkington, Jaine K. Blayney et al.|Journal of Clinical Oncology|2017Cited by 1
Expression of Glucose Transporter 1 (GLUT1) is a marker for Poor Prognosis in Oesophageal Adenocarcinoma.Richard Turkington, Martin Eatock, Gerald Li et al.|Unknown|2015Cited by 0
Association of a DNA damage response deficiency (DDRD) assay with prognosis in resected esophageal and gastric adenocarcinoma.Richard Turkington, Richard D. Kennedy, Laura A. Knight et al.|Journal of Clinical Oncology|2017Cited by 0